World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part I: Anxiety disorders.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bandelow Borwin, Allgulander Christer, Baldwin David S, Costa Daniel Lucas da Conceição, Denys Damiaan, Dilbaz Nesrin, Domschke Katharina, Eriksson Elias, Fineberg Naomi A, Hättenschwiler Josef, Hollander Eric, Kaiya Hisanobu, Karavaeva Tatiana, Kasper Siegfried, Katzman Martin, Kim Yong-Ku, Inoue Takeshi, Lim Leslie, Masdrakis Vasilios, Menchón José M, Miguel Euripedes C, Möller Hans-Jürgen, Nardi Antonio E, Pallanti Stefano, Perna Giampaolo, Rujescu Dan, Starcevic Vladan, Stein Dan J, Tsai Shih-Jen, Van Ameringen Michael, Vasileva Anna, Wang Zhen, Zohar Joseph
Аннотация
METHOD: A consensus panel of 33 international experts representing 22 countries developed recommendations based on efficacy and acceptability of available treatments. In total, 1007 RCTs for the treatment of these disorders in adults, adolescents, and children with medications, psychotherapy and other non-pharmacological interventions were evaluated, applying the same rigorous methods that are standard for the assessment of medications.
RESULT: This paper, Part I, contains recommendations for the treatment of panic disorder/agoraphobia (PDA), generalised anxiety disorder (GAD), social anxiety disorder (SAD), specific phobias, mixed anxiety disorders in children and adolescents, separation anxiety and selective mutism. Selective serotonin reuptake inhibitors (SSRI) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are first-line medications. Cognitive behavioural therapy (CBT) is the first-line psychotherapy for anxiety disorders. The expert panel also made recommendations for patients not responding to standard treatments and recommendations against interventions with insufficient evidence.
CONCLUSION: It is the goal of this initiative to provide treatment guidance for these disorders that has validity throughout the world.